Legal Representation
Attorney
Kathryn E. Smith
USPTO Deadlines
Next Deadline
1141 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-09-13)
Due Date
September 13, 2028
Grace Period Ends
March 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 2, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 13, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 13, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 28, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 28, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 8, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 18, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 17, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 17, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 17, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 12, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Dec 1, 2021 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Dec 1, 2021 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Dec 1, 2021 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Nov 24, 2021 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| May 24, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 24, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 24, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 31, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 30, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 30, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 8, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 8, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 8, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 5, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 6, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 4, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets
Classification
International Classes
005